Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

29,773 signal articles · 72 in last 24h · 148,348 total before filter · latest 1h ago
72last 24h
975last 7d
109● bullish (7d)
124● bearish (7d)
212publishers
AllMacro369Earnings115M&A98Regulatory8Product11Analyst11
✕ clear all filtersticker: PLTRsentiment: neutralSentiment:bullishneutralbearishshow all (incl. clickbait)
Did You Pay For Palantir's Guidance Or For Something Else?
Trefis4d agoneutral
Did You Pay For Palantir's Guidance Or For Something Else?

Palantir Technologies (PLTR) raised its 2026 revenue guidance in August, and the stock gained about 32% across the release. The easy read is that the market was paying for the bigger number. It was not. At the multiple the market was already paying, that raise is worth about $8 a share, and the tape handed over close to $40.

3 Software Stocks Recently Raising Guidance
Zacks22d agoneutral
3 Software Stocks Recently Raising Guidance

Guidance upgrades are generally one of the most bullish things to watch for in earnings season, as renewed outlooks can often lead to positive EPS revisions, one of the strongest drivers of a stock's near-term movement.

Q2 Earnings Season Standout Performers: PLTR, MSFT
Zacks32d agoneutral
Q2 Earnings Season Standout Performers: PLTR, MSFT

The Q2 earnings season continues to wind down, which has overall shown immense strength with outsized growth. There have been several standout releases during the Q2 earnings cycle, including those from Palantir (PLTR) and Microsoft (MSFT).

Inovio Pharmaceuticals Q2 Earnings Call Highlights
MarketBeat37d agoneutral
Inovio Pharmaceuticals Q2 Earnings Call Highlights

Inovio Pharmaceuticals (NASDAQ:INO) said the U.S. Food and Drug Administration has completed several key steps in its review of the company’s biologics license application for INO-3107, an investigational treatment for recurrent respiratory papillomatosis, or RRP, while the company continues prepara

Vitalhub Q2 Earnings Call Highlights
MarketBeat40d agoneutral
Vitalhub Q2 Earnings Call Highlights

Vitalhub (TSE:VHI) reported second-quarter 2026 revenue of CAD 31.7 million, up 33% from the prior-year period, while annual recurring revenue surpassed CAD 100 million for the first time. Chief Financial Officer Brian Goffenberg said the company ended June with CAD 101.5 million in annual recurrin

Zeta Global Q2 Earnings Call Highlights
MarketBeat40d agoneutral
Zeta Global Q2 Earnings Call Highlights

Zeta Global (NYSE:ZETA) reported second-quarter 2026 revenue of $443 million, up 44% from a year earlier, or 28% excluding revenue from mergers and acquisitions. The company said the result marked its 20th consecutive quarter of beating and raising its outlook. Adjusted EBITDA rose 56% year over ye

USA Today Q2 Earnings Call Highlights
MarketBeat41d agoneutral
USA Today Q2 Earnings Call Highlights

USA Today (NYSE:TDAY) reported second-quarter 2026 revenue of $536.3 million, down 8.3% from a year earlier, as lower digital advertising revenue and quarter-to-quarter variability in content licensing offset gains in digital-only subscriptions and other digital revenue streams. The company generat

Innodata Q2 Earnings Call Highlights
MarketBeat43d agoneutral
Innodata Q2 Earnings Call Highlights

Innodata (NASDAQ:INOD) reported record second-quarter results for 2026, with revenue, adjusted gross profit, adjusted EBITDA and cash reaching new highs as the company continued to expand its work with AI model developers and large technology customers. Revenue for the quarter was $92.1 million, up

Veteran analyst rethinks Palantir stock after earnings
TheStreet45d agoneutral
Veteran analyst rethinks Palantir stock after earnings

Palantir stock has struggled for months, but the company may have just given investors some hope again. Shares of Palantir surged 29.45% on Aug. 4, the trading day after Palantir reported second-quarter results that topped Wall Street's expectations. The company posted adjusted earnings of 41 cents ...

Morning Bid: Earnings overload
Reuters46d agoneutral
Morning Bid: Earnings overload

August 4 (Reuters) - What matters in U.S. and global markets today By Mike Dolan, Editor-at-Large, Finance and Markets World markets turned quieter on Tuesday after yesterday's equity rally and oil

Alex Karp Rips Frontier AI Labs for 'Marxist Overtones' After Palantir's Blowout Earnings— Says They Want to 'Colonize Your Enterprise'
Benzinga46d agoneutral
Alex Karp Rips Frontier AI Labs for 'Marxist Overtones' After Palantir's Blowout Earnings— Says They Want to 'Colonize Your Enterprise'

Palantir Technologies Inc. (NASDAQ:PLTR) CEO Alex Karp reiterated on Monday that he believes AI frontier labs are not trustworthy enough for enterprise use. During the earnings call, following the company’s robust results, the CEO argued that companies should support technologies that strengthen U.S. interests rather than benefit adversaries, while criticizing what he described as a small group of elites controlling economic gains at others’ expense. Karp argued that enterprises are effectively